Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP584417.RAh7lYw84JTzeuy3SoLhN2rw76t3vcDzedpasuc9CKaXM130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584417.RAh7lYw84JTzeuy3SoLhN2rw76t3vcDzedpasuc9CKaXM130_provenance.
• NP879046.RAaBSerucX2LRU3NgrKmdBb6WNFL8XlKnBlA0A99Cp7KQ130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879046.RAaBSerucX2LRU3NgrKmdBb6WNFL8XlKnBlA0A99Cp7KQ130_provenance.
• NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_provenance.
• NP896913.RA4I6oJlraN5fkFvpSGY8wO2PItzO5N4v2_uKzGlN0Dk0130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896913.RA4I6oJlraN5fkFvpSGY8wO2PItzO5N4v2_uKzGlN0Dk0130_provenance.
• NP621738.RAaXQ2Rc2Lma0b7rxoco3MGJwOLX81PtpDEdAfLrRJgUQ130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621738.RAaXQ2Rc2Lma0b7rxoco3MGJwOLX81PtpDEdAfLrRJgUQ130_provenance.
• NP622982.RADUhPV1N47Thi4RSMey3hmMoWUcFd08zNFGJnWQO5kqc130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622982.RADUhPV1N47Thi4RSMey3hmMoWUcFd08zNFGJnWQO5kqc130_provenance.
• NP232596.RAk3ytDf_9TPhZdhsLnP2DfWBtFdOB8-bleh-5m8oDBKo130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232596.RAk3ytDf_9TPhZdhsLnP2DfWBtFdOB8-bleh-5m8oDBKo130_provenance.
• NP715129.RAolG9zjYDhv0zH03gQp-8ccOVIaqalnJMjnbYQZzPwe0130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715129.RAolG9zjYDhv0zH03gQp-8ccOVIaqalnJMjnbYQZzPwe0130_provenance.
• NP715133.RAjjdE1MuywrFST-NaQX7WmRqIJe4b9xpFo-nFC7lNSzE130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715133.RAjjdE1MuywrFST-NaQX7WmRqIJe4b9xpFo-nFC7lNSzE130_provenance.
• NP624298.RA8SQxWuyym89qu6YftmizU98PihDamcyqZEUuwBIM23M130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624298.RA8SQxWuyym89qu6YftmizU98PihDamcyqZEUuwBIM23M130_provenance.
• NP625438.RAyXtjIRcCl8cIF8QyhBKOiDbuUXh3oR5N9UxCfhyuhgs130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625438.RAyXtjIRcCl8cIF8QyhBKOiDbuUXh3oR5N9UxCfhyuhgs130_provenance.
• NP715127.RAKg-71qsltbDRLxgcft1bUvpyqngxU4iQemIhx53VjmE130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715127.RAKg-71qsltbDRLxgcft1bUvpyqngxU4iQemIhx53VjmE130_provenance.
• NP715131.RAzU8jWaqd46TUaAffl3CRdsDv3SWE1L4IytJSFpynzWQ130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715131.RAzU8jWaqd46TUaAffl3CRdsDv3SWE1L4IytJSFpynzWQ130_provenance.
• NP715132.RAxWWKUoE7RsMdJ4s1lKyofNxumbKd0s-e7FfOF7-D7WU130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715132.RAxWWKUoE7RsMdJ4s1lKyofNxumbKd0s-e7FfOF7-D7WU130_provenance.